Predicting the survival probability of functional neuroendocrine tumors treated with peptide receptor radionuclide therapy: Serbian experience

Predicting the survival probability of functional neuroendocrine tumors treated with peptide receptor radionuclide therapy: Serbian experience

IntroductionPeptide receptor radionuclide therapy (PRRT) is a treatment option for well-differentiated, somatostatin receptor positive, unresectable or/and metastatic neuroendocrine tumors (NETs). Although high disease control rates seen with PRRT a significant number NET patients have a short progr...

Full description

Bibliographic Details
Main Authors: Vladimir Vukomanovic, Katarina Vuleta Nedic, Marija Zivkovic Radojevic, Aleksandar Dagovic, Neda Milosavljevic, Marina Markovic, Vladimir Ignjatovic, Ivana Simic Vukomanovic, Svetlana Djukic, Marijana Sreckovic, Milena Backovic, Marko Vuleta, Aleksandar Djukic, Verica Vukicevic, Vesna Ignjatovic
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Endocrinology
Subjects:
NET
PRRT
functional tumors
overall survival
progression free survival
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2023.1270421/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2023.1270421/full

Similar Items